Team
Our team combines expertise in in vitro immunogenicity testing, humanized mouse models and mass spectrometry-based immunopeptidomics with the aim to develop personalized epitope-centric immunotherapies such as a therapeutic vaccine against malignancies caused by human papillomaviruses (HPV).
← Back to Immunotherapy and Immunoprevention